Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

NCT05872204 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Low Grade Serous Ovarian Carcinoma
Adult Type Granulosa Cell Tumor

Interventions

DRUG: Abemaciclib
DRUG: Letrozole

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]
[object Object]
[object Object]